.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
US Army
Healthtrust
Colorcon
Chubb
Citi
Harvard Business School
Mallinckrodt
Deloitte
Federal Trade Commission

Generated: June 28, 2017

DrugPatentWatch Database Preview

PREVALITE Drug Profile

« Back to Dashboard

What is the patent landscape for Prevalite, and when can generic versions of Prevalite launch?

Prevalite is a drug marketed by Upsher Smith and is included in one NDA.

The generic ingredient in PREVALITE is cholestyramine. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for Tradename: PREVALITE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PREVALITE at DailyMed

Pharmacology for Tradename: PREVALITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith
PREVALITE
cholestyramine
POWDER;ORAL073263-001Feb 22, 1996ABRXNoNo► Subscribe► Subscribe
Upsher Smith
PREVALITE
cholestyramine
POWDER;ORAL073263-002Oct 30, 1997ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
McKinsey
Farmers Insurance
Chinese Patent Office
AstraZeneca
Cipla
Mallinckrodt
Citi
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot